Cemex SAB de CV ADR's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Cemex SAB de CV ADR reported revenue of $16.1B (-0.4% year on year) and net income of $970.0M (+1.0% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Revenues | $16.1B | $16.2B | $17.4B | $15.6B |
| Cost of sales | ($10.8B) | ($10.8B) | ($11.5B) | ($10.8B) |
| Gross profit | $5.3B | $5.4B | $5.9B | $4.8B |
| Operating expenses | ($3.5B) | ($3.6B) | ($3.7B) | ($3.3B) |
| Operating earnings before other expenses, net | $1.8B | $1.8B | $2.1B | $1.6B |
| Other expenses, net | ($784.0M) | ($7.0M) | ($265.0M) | ($467.0M) |
| Operating earnings | $1.0B | $1.8B | $1.8B | $1.1B |
| Financial expense | ($454.0M) | ($555.0M) | ($531.0M) | ($401.0M) |
| Financial income and other items, net | $148.0M | ($379.0M) | $33.0M | $47.0M |
| Share of profit of equity accounted investments | $90.0M | $93.0M | $98.0M | $30.0M |
| Earnings before income tax | $789.0M | $980.0M | $1.4B | $770.0M |
| Income tax | ($385.0M) | ($67.0M) | ($1.3B) | ($209.0M) |
| Net income from continuing operations | $404.0M | $913.0M | $199.0M | $561.0M |
| Discontinued operations | $566.0M | $47.0M | $0 | $324.0M |
| CONSOLIDATED NET INCOME | $970.0M | $960.0M | $199.0M | $885.0M |
| Non-controlling interest net income | $10.0M | $21.0M | $17.0M | $27.0M |
| CONTROLLING INTEREST NET INCOME | $960.0M | $939.0M | $182.0M | $858.0M |
| Basic earnings per share | $0.02 | $0.02 | $0.00 | $0.02 |
| Basic earnings per share from continuing operations | $0.01 | $0.02 | $0.00 | $0.01 |
| Diluted earnings per share | $0.02 | $0.02 | $0.00 | $0.02 |
| Diluted earnings per share from continuing operations | $0.01 | $0.02 | $0.00 | $0.01 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $1.8B | $864.0M | $624.0M | $495.0M |
| Trade accounts receivable | $1.8B | $1.6B | $1.8B | $1.6B |
| Other accounts receivable | $834.0M | $715.0M | $650.0M | $535.0M |
| Inventories | $1.5B | $1.5B | $1.8B | $1.7B |
| Assets held for sale and other current assets | $144.0M | $370.0M | $191.0M | $183.0M |
| Total current assets | $6.1B | $5.0B | $5.0B | $4.5B |
| Investments in associates and joint ventures | $792.0M | $753.0M | $729.0M | $640.0M |
| Other investments and non-current accounts receivable | $212.0M | $256.0M | $340.0M | $293.0M |
| Property, machinery and equipment, net and assets for the right-of-use, net | $12.2B | $11.2B | $12.5B | $11.3B |
| Intangible assets other than goodwill | $2.0B | — | — | — |
| Goodwill | $7.2B | — | — | — |
| Deferred income tax assets | $516.0M | $673.0M | $363.0M | $411.0M |
| Total non-current assets | $22.8B | $22.3B | $23.4B | $21.9B |
| TOTAL ASSETS | $28.9B | $27.3B | $28.4B | $26.4B |
| Current debt | $1.2B | $189.0M | $25.0M | $51.0M |
| Other current financial obligations | $948.0M | $927.0M | $950.0M | $936.0M |
| Trade accounts payable | $3.1B | $3.1B | $3.1B | $3.0B |
| Income taxes payable | $438.0M | $469.0M | $1.1B | $368.0M |
| Other current liabilities | $1.7B | $1.3B | $1.6B | $1.2B |
| Total current liabilities | $7.3B | $6.1B | $6.8B | $5.5B |
| Non-current debt | $4.5B | $5.3B | $6.2B | $6.9B |
| Other non-current financial obligations | $868.0M | $902.0M | $986.0M | $918.0M |
| Pensions and other post-employment benefits | $588.0M | $559.0M | $735.0M | $695.0M |
| Deferred income tax liabilities | $601.0M | $548.0M | $443.0M | $394.0M |
| Other non-current liabilities | $1.4B | $1.4B | $1.2B | $1.1B |
| Total non-current liabilities | $8.0B | $8.7B | $9.5B | $10.0B |
| TOTAL LIABILITIES | $15.3B | $14.8B | $16.3B | $15.5B |
| Common stock and additional paid-in capital | $7.7B | $7.7B | $7.7B | $7.8B |
| Other equity reserves and subordinated notes | ($446.0M) | ($770.0M) | ($363.0M) | ($1.6B) |
| Retained earnings | $6.1B | $5.2B | $4.4B | $4.2B |
| Total controlling interest | $13.3B | $12.2B | $11.8B | $10.5B |
| Non-controlling interest | $308.0M | $301.0M | $352.0M | $408.0M |
| TOTAL STOCKHOLDERS' EQUITY | $13.6B | $12.5B | $12.1B | $10.9B |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $28.9B | $27.3B | $28.4B | $26.4B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Consolidated net income | $970.0M | $960.0M | $199.0M | $885.0M |
| Discontinued operations | $566.0M | $47.0M | $0 | $324.0M |
| Net income from continuing operations | $404.0M | $913.0M | $199.0M | $561.0M |
| Depreciation and amortization of assets | $1.3B | $1.3B | $1.2B | $1.1B |
| Impairment losses of long-lived assets | $538.0M | $122.0M | $43.0M | $442.0M |
| Share of profit of equity accounted investments | ($90.0M) | ($93.0M) | ($98.0M) | ($30.0M) |
| Results on sale of associates, fixed assets and others | ($76.0M) | ($172.0M) | — | — |
| Financial expense, financial income and other financial items, net | $306.0M | $934.0M | $498.0M | $354.0M |
| Income taxes | $385.0M | $67.0M | $1.3B | $209.0M |
| Cash flows provided by operating activities from continuing operations | $2.7B | $3.3B | $3.3B | $2.1B |
| Interest paid | ($446.0M) | ($621.0M) | ($581.0M) | ($493.0M) |
| Income taxes paid | ($301.0M) | ($878.0M) | ($538.0M) | ($188.0M) |
| Net cash flows provided by operating activities from continuing operations | $2.0B | $1.8B | $2.2B | $1.5B |
| Net cash flows (used in) provided by operating activities from discontinued operations | ($4.0M) | $141.0M | $0 | $6.0M |
| Net cash flows provided by operating activities after interest and income taxes | $2.0B | $1.9B | $2.2B | $1.5B |
| Investment in property, machinery and equipment, net | ($947.0M) | ($1.0B) | ($968.0M) | ($909.0M) |
| Investment in intangible assets, net | ($265.0M) | ($296.0M) | ($207.0M) | ($151.0M) |
| Disposal (acquisition) of subsidiaries and associates, net | $965.0M | $1.0B | — | — |
| Non-current assets and others, net | $57.0M | $35.0M | $24.0M | ($12.0M) |
| Cash flows used in investing activities from continuing operations | ($190.0M) | ($241.0M) | ($1.3B) | ($731.0M) |
| Net cash flows used in investing activities from discontinued operations | ($7.0M) | ($87.0M) | $0 | ($1.0M) |
| Net cash flows used in investing activities | ($197.0M) | ($328.0M) | ($1.3B) | ($732.0M) |
| Proceeds from new debt instruments | $2.1B | $5.0B | $2.9B | $2.0B |
| Debt repayments | ($2.2B) | ($5.5B) | ($3.8B) | ($2.4B) |
| Issuance of subordinated notes | $989.0M | — | $992.0M | $0 |
| Other financial obligations, net | ($285.0M) | ($292.0M) | ($274.0M) | ($197.0M) |
| Dividends paid | ($127.0M) | ($90.0M) | — | — |
| Shares in trust for future deliveries under share-based compensation | -49.0M | -52.0M | -45.0M | -36.0M |
| Repayment of subordinated notes and changes in non-controlling interests | ($1.0B) | — | — | — |
| Derivative financial instruments | ($5.0M) | ($37.0M) | ($189.0M) | $34.0M |
| Coupons on subordinated notes | ($99.0M) | ($143.0M) | ($120.0M) | ($51.0M) |
| Non-current liabilities, net | ($61.0M) | ($188.0M) | ($101.0M) | ($172.0M) |
| Net cash flows used in financing activities | ($796.0M) | ($1.3B) | ($701.0M) | ($961.0M) |
| Increase in cash and cash equivalents from continuing operations | $993.0M | $259.0M | $118.0M | ($223.0M) |
| Increase (decrease) in cash and cash equivalents from discontinued operations | ($11.0M) | $54.0M | $0 | $5.0M |
| Foreign currency translation effect on cash | ($24.0M) | ($73.0M) | $11.0M | $100.0M |
| Cash and cash equivalents at beginning of period | $864.0M | $624.0M | $495.0M | $613.0M |
| CASH AND CASH EQUIVALENTS AT END OF PERIOD | $1.8B | $864.0M | $624.0M | $495.0M |
| Trade accounts receivable | ($34.0M) | $56.0M | ($27.0M) | ($208.0M) |
| Other accounts receivable and other assets | $61.0M | ($45.0M) | $21.0M | ($23.0M) |
| Inventories | $83.0M | $196.0M | $68.0M | ($464.0M) |
| Trade accounts payable | ($225.0M) | $159.0M | ($45.0M) | $290.0M |
| Other accounts payable and accrued expenses | $83.0M | ($135.0M) | $175.0M | $15.0M |
| Decrease (increase) in working capital, excluding income taxes | ($32.0M) | $231.0M | $192.0M | ($390.0M) |
Cemex SAB de CV ADR score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.